Followers

0
0
5
5
.
3
3
9
9
0
0
,
1
1
9.80 (0.90%)

As on 22 Jan, 2026 | 15:54

Open Trading A/c
Day Range
1,081.10
1,111.00
LH
52 Week Range
1,074.40
2,114.00
LH
Volume
* i
Bid / Ask
15,227.00
1,093.50 / 18.00

Epigral Announcements

Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve...

20 Jan, 2026 | 12:51pm • Source: BSE

Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 13th January, 2026.

12 Jan, 2026 | 03:10pm • Source: BSE

Epigral Limited submits Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended 31.12.2025.

07 Jan, 2026 | 06:19pm • Source: BSE

Intimation for receipt of Order from Income Tax Department.

01 Jan, 2026 | 04:23pm • Source: BSE

Notice of closure of Trading Window w.e.f. 1st January, 2026.

26 Dec, 2025 | 03:39pm • Source: BSE

Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 23rd December, 2025

22 Dec, 2025 | 05:56pm • Source: BSE

Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 1st December, 2025

28 Nov, 2025 | 02:36pm • Source: BSE

Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on 25.11.2025.

21 Nov, 2025 | 11:12am • Source: BSE

Epigral Limited has informed the Exchange about Participation in Conference on 19th November, 2025 and 20th November, 2025

17 Nov, 2025 | 10:34am • Source: NSE

Epigral Limited has informed the Exchange about Participation in Conference on 19th November, 2025 and 20th November, 2025.

17 Nov, 2025 | 10:27am • Source: BSE

Epigral Limited has informed the Exchange about Participation in Conference on 19th November, 2025 and 20th November, 2025.

17 Nov, 2025 | 10:27am • Source: BSE

Epigral Limited submits copy of Newspaper Publication pertaining to Un-Audited Financial Results - 30.09.2025

12 Nov, 2025 | 10:51am • Source: BSE

Epigral Limited submits Audio Recording of Conference Call discussing Q2 FY2026 Results.

10 Nov, 2025 | 09:22pm • Source: BSE

Epigral Limited has informed the Exchange regarding Appointment of MR. RAKESH AGRAWAL as Chief Financial Officer of the company w.e.f. November 10, 2025

10 Nov, 2025 | 01:51pm • Source: NSE

Epigral Limited has informed the Exchange regarding a press release dated November 10, 2025, titled "Press Release on Un-Audited Financial Results Q2 FY26

10 Nov, 2025 | 01:48pm • Source: NSE

UNAUDITED FINANCIAL RESULTS AS ON 30.09.2025.

10 Nov, 2025 | 01:46pm • Source: BSE

UNAUDITED FINANCIAL RESULTS AS ON 30.09.2025.

10 Nov, 2025 | 01:46pm • Source: BSE

Appointment of Mr. Rakesh Agrawal as a Chief Financial Officer and Key Managerial Personnel of the Company w.e.f. 10.11.2025.

10 Nov, 2025 | 01:42pm • Source: BSE

Appointment of Mr. Rakesh Agrawal as a Chief Financial Officer and Key Managerial Personnel of the Company w.e.f. 10.11.2025.

10 Nov, 2025 | 01:42pm • Source: BSE

Investor Presentation on Un-Audited Financial Results - Q2 FY26.

10 Nov, 2025 | 01:37pm • Source: BSE